[{"address1": "4 Kingsbury Avenue", "city": "Watertown", "state": "MA", "zip": "02472", "country": "United States", "phone": "617 607 0800", "fax": "617 607 0530", "website": "https://www.enanta.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. The company's product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; EDP-938 and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; and Glecaprevir, which is in the market for the treatment of chronic infection with hepatitis C virus or HCV. Enanta Pharmaceuticals, Inc. has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. The company was incorporated in 1995 and is headquartered in Watertown, Massachusetts.", "fullTimeEmployees": 131, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jay R. Luly Ph.D.", "age": 68, "title": "President, CEO & Director", "yearBorn": 1956, "fiscalYear": 2024, "totalPay": 1231428, "exercisedValue": 0, "unexercisedValue": 67815}, {"maxAge": 1, "name": "Mr. Paul J. Mellett Jr.", "age": 69, "title": "Chief Financial & Administrative Officer", "yearBorn": 1955, "fiscalYear": 2024, "totalPay": 671700, "exercisedValue": 0, "unexercisedValue": 21320}, {"maxAge": 1, "name": "Dr. Yat Sun Or Ph.D.", "age": 72, "title": "Chief Scientific Officer", "yearBorn": 1952, "fiscalYear": 2024, "totalPay": 740108, "exercisedValue": 0, "unexercisedValue": 22091}, {"maxAge": 1, "name": "Mr. Matthew P. Kowalsky J.D.", "age": 51, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 575652, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Scott T. Rottinghaus M.D.", "age": 50, "title": "Chief Medical Office", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 776138, "exercisedValue": 43483, "unexercisedValue": 14728}, {"maxAge": 1, "name": "Ms. Jennifer  Viera", "title": "Executive Director of Investor Relations & Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nathaniel S. Gardiner J.D.", "age": 70, "title": "Consultant", "yearBorn": 1954, "fiscalYear": 2024, "totalPay": 672675, "exercisedValue": 49136, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Tara Lynn Kieffer Ph.D.", "age": 46, "title": "Chief Product Strategy Officer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 496852, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brendan  Luu", "age": 49, "title": "Chief Business Officer", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 622856, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 4, "compensationRisk": 6, "shareHolderRightsRisk": 8, "overallRisk": 6, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.41, "open": 7.21, "dayLow": 7.21, "dayHigh": 7.87, "regularMarketPreviousClose": 7.41, "regularMarketOpen": 7.21, "regularMarketDayLow": 7.21, "regularMarketDayHigh": 7.87, "payoutRatio": 0.0, "beta": 0.772, "forwardPE": -1.5560166, "volume": 240314, "regularMarketVolume": 240314, "averageVolume": 198938, "averageVolume10days": 241150, "averageDailyVolume10Day": 241150, "bid": 5.54, "ask": 9.35, "bidSize": 2, "askSize": 2, "marketCap": 160324496, "fiftyTwoWeekLow": 4.09, "fiftyTwoWeekHigh": 17.235, "priceToSalesTrailing12Months": 2.4870777, "fiftyDayAverage": 5.7824, "twoHundredDayAverage": 7.826925, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 181167472, "profitMargins": -1.49566, "floatShares": 14358649, "sharesOutstanding": 21376600, "sharesShort": 2721617, "sharesShortPriorMonth": 2957157, "sharesShortPreviousMonthDate": 1745971200, "dateShortInterest": 1748563200, "sharesPercentSharesOut": 0.1273, "heldPercentInsiders": 0.06565, "heldPercentInstitutions": 0.87518, "shortRatio": 22.35, "shortPercentOfFloat": 0.1353, "impliedSharesOutstanding": 21376600, "bookValue": 4.376, "priceToBook": 1.713894, "lastFiscalYearEnd": 1727654400, "nextFiscalYearEnd": 1759190400, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -96415000, "trailingEps": -4.53, "forwardEps": -4.82, "enterpriseToRevenue": 2.81, "enterpriseToEbitda": -1.831, "52WeekChange": -0.37862468, "SandP52WeekChange": 0.09203708, "quoteType": "EQUITY", "currentPrice": 7.5, "targetHighPrice": 24.0, "targetLowPrice": 5.0, "targetMeanPrice": 15.2, "targetMedianPrice": 20.0, "recommendationMean": 2.2, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 193375008, "totalCashPerShare": 9.046, "ebitda": -98944000, "totalDebt": 216142000, "quickRatio": 5.093, "currentRatio": 5.286, "totalRevenue": 64463000, "debtToEquity": 231.074, "revenuePerShare": 3.035, "returnOnAssets": -0.17329, "returnOnEquity": -0.74265, "grossProfits": 64463000, "freeCashflow": -72374624, "operatingCashflow": -55464000, "revenueGrowth": -0.125, "grossMargins": 1.0, "ebitdaMargins": -1.5349001, "operatingMargins": -1.6432401, "financialCurrency": "USD", "symbol": "ENTA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "exchange": "NMS", "corporateActions": [], "shortName": "Enanta Pharmaceuticals, Inc.", "longName": "Enanta Pharmaceuticals, Inc.", "postMarketTime": 1749858048, "regularMarketTime": 1749844801, "messageBoardId": "finmb_345286", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 1.21458, "regularMarketPrice": 7.5, "fiftyTwoWeekLowChange": 3.4099998, "fiftyTwoWeekLowChangePercent": 0.8337408, "fiftyTwoWeekRange": "4.09 - 17.235", "fiftyTwoWeekHighChange": -9.735001, "fiftyTwoWeekHighChangePercent": -0.564839, "fiftyTwoWeekChangePercent": -37.86247, "earningsTimestamp": 1747080060, "earningsTimestampStart": 1754305140, "earningsTimestampEnd": 1754654400, "earningsCallTimestampStart": 1715027400, "earningsCallTimestampEnd": 1715027400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -4.53, "epsForward": -4.82, "epsCurrentYear": -3.894, "priceEpsCurrentYear": -1.92604, "fiftyDayAverageChange": 1.7175999, "fiftyDayAverageChangePercent": 0.29703927, "twoHundredDayAverageChange": -0.3269248, "twoHundredDayAverageChangePercent": -0.04176925, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.2 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1363872600000, "postMarketChangePercent": -3.5999997, "postMarketPrice": 7.23, "postMarketChange": -0.26999998, "regularMarketChange": 0.0900002, "regularMarketDayRange": "7.21 - 7.87", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 198938, "displayName": "Enanta Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-06-14"}]